Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 1/20 | 0.33 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL754915 | 0.97 | CYP3A4 (0.32) | TERTAMY1ACYP3A4TSHRMAPK1 | |
| SCHEMBL756006 | 0.89 | — | — | |
| SCHEMBL756003 | 0.87 | MAPK1 (0.39) | MAPK1 | |
| SCHEMBL15131714 | 0.78 | TERT (0.39) | TERTCYP3A4TSHRMAPK1TDP1 | |
| SCHEMBL12403114 | 0.78 | TSHR (0.37) | AMY1ACYP3A4TSHRMAPK1 | |
| SCHEMBL12403141 | 0.78 | NQO2 (0.40) | TSHRMAPK1TDP1 | |
| SCHEMBL18828940 | 0.76 | PTPN1 (0.35) | — | |
| SCHEMBL2347027 | 0.75 | TSHR (0.38) | AMY1ACYP3A4TSHRMAPK1 | |
| SCHEMBL120843 | 0.75 | BCHE (0.37) | TERTCYP3A4TSHRMAPK1TDP1 | |
| SCHEMBL753654 | 0.75 | GABRA1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8138355-B2 | Heteroacene derivative, tetrahaloterphenyl derivative, and processes for producing the same | TOSOH CORPORATION (JP) | 2012-03-20 | — | — | US | disclosed |
| US-20090261300-A1 | HETEROACENE DERIVATIVE, TETRAHALOTERPHENYL DERIVATIVE, AND PROCESSES FOR PRODUCING THE SAME | TOSOH CORPORATION (JP) | 2009-10-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090261300-A1 | HETEROACENE DERIVATIVE, TETRAHALOTERPHENYL DERIVATIVE, AND PROCESSES FOR PRODUCING THE SAME | AS3MT, TERT, TEAD1 | TERT 2/4885AMY1A 1684/4885CYP3A4 754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.